Conditions: Scalp Psoriasis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 78
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate the safety and efficacy of once daily use of LEO 80185 gel in adolescent subjects (aged 12 to 17) with scalp psoriasis. LEO 80185 gel has marketing approval in many countries under the brand names Xamiol® gel and Taclonex Scalp® Topical Suspension for the treatment of scalp psoriasis in adults. No studies have been performed in subjects younger than 18 years

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)
Intervention descriptions: intervention 1: Once daily application

Protocol document: